Orexo AB
USPTO PatentsView assignee record - 28 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Orexo ranks #11,035 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 6 technology areas.
- #11,035
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (40.0/100)
- 21.7
- avg claims per patent
- +27%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11035 · Foreign Corporation #11,035 · 28 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 28 grants
- UPPER-Q #11,035/49,997
- PHOTO-FINISH NuCana
- CPC-NARROW A61K · 6 areas
- INNOV-THIN 40.0/100
- CLAIMS-DENSE 21.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +27% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: NuCana plc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Orexo’s 40.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Orexo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Heifeng Zhizao… · near
Heifeng Zhizao… · near
40 score
- Laboratorios… · near
Laboratorios… · near
40 score
- Lagom Kitchen · near
Lagom Kitchen · near
40 score
- Orexo AB · this assignee
Orexo AB · this assignee
40 score
- Peridot Print · near
Peridot Print · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Orexo's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Orexo?
Each dot is one of Orexo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orexo’s own 21.7 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Orexo's grants concentrate
Orexo AB is a focused PatentsView assignee: 6 CPC subclasses with 89.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2022. By volume, Orexo sits between NuCana plc and Open Text GXS ULC.
Orexo's three-year grant acceleration
Orexo AB shows 7 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Orexo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nucana
NuCana plc
28 patents
- O2 Partners
O2 Partners, LLC
28 patents
- Ondal Medical Sys…
Ondal Medical Systems GMBH
28 patents
- Opko Biologics
Opko Biologics Ltd.
28 patents
- Orthosoft
ORTHOsoft, Inc.
28 patents
- Onanon
Onanon, Inc.
28 patents
- Opel Solar
Opel Solar, Inc.
28 patents
- Open Text GXS ULC
Open Text GXS ULC
28 patents
- Orexo AB ◀
Orexo AB
28 patents
What this shows Orexo holds 28 patents at rank #11,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Orexo
By rank, the assignees closest to #11,030 in granted patent volume.
- NuCana plc #11,026 · 28 patents
- O2 Partners, LLC #11,027 · 28 patents
- Ondal Medical Systems GMBH #11,028 · 28 patents
- Opko Biologics Ltd. #11,029 · 28 patents
- ORTHOsoft, Inc. #11,031 · 28 patents
- Onanon, Inc. #11,032 · 28 patents
- Opel Solar, Inc. #11,033 · 28 patents
- Open Text GXS ULC #11,034 · 28 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Orexo's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Orexo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Orexo ranks #906 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Orexo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 14.3% |
| 2016 | 5 | 17.9% |
| 2017 | 2 | 7.1% |
| 2020 | 3 | 10.7% |
| 2021 | 4 | 14.3% |
| 2022 | 1 | 3.6% |
| 2023 | 2 | 7.1% |
| 2024 | 4 | 14.3% |
| 2025partial year | 3 | 10.7% |
Which technologies does Orexo AB patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Orexo AB's patent record in context - here's where to go next.
- Orexo AB's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 89.3% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #11,035 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Orexo AB against NuCana plc, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.